Why MaxLinear Stock Gained 50.7% Last Month

MaxLinear shares rose 50.7% in September and 549% over the past year, driven by accelerating demand for optical DSP chips used in AI data-center networking. Management has lifted its optical data-center revenue outlook from more than $100 million at the start of the year to a current midpoint of $220 million, with 26-28 week order lead times and pricing expected to remain firm through 2027. However, the stock trades at 39x forward earnings—well above Credo's 22.7x and Broadcom's 18.4x—and remains volatile, making the Oct. 28 Q3 report a key catalyst.

Analysis

MXL’s rerating now embeds both sustained optical demand and rapid share capture, but those are economically distinct assumptions. Demand can remain strong while MXL’s gains stall if hyperscale customers prioritize qualified incumbent module/DSP platforms; design-win conversion and customer concentration matter more than industry lead times. The relevant downside is not merely a cyclical semiconductor pullback: a modest miss in optical revenue mix, gross-margin progression, or 2027 order visibility could compress the valuation premium sharply because the equity has little room for execution friction.

The better second-order beneficiary may be CRDO, whose connectivity exposure offers a cleaner way to own AI-cluster scaling without requiring an aggressive share-gain thesis from a smaller supplier. AVGO is the lower-beta alternative: optical interconnect demand reinforces its broader custom silicon and switching ecosystem, while its diversified earnings base limits a single-program qualification risk. Conversely, AI spending scrutiny or a security-driven pause in deployment schedules would hit high-multiple, less-diversified optical suppliers first; MXL should have greater downside beta than AVGO.

Near term, the Oct. 28 report is a binary validation event. Focus on whether backlog converts into firm purchase commitments, whether pricing remains stable after initial supply tightness, and whether management can quantify customer/program breadth rather than reiterate a market-size narrative. Over 6-18 months, the key issue is whether higher optical revenue becomes durable gross-profit expansion; if it instead requires pricing concessions, expedited supply, or elevated customer-support expense, the current multiple is vulnerable even with revenue growth intact.

Contrarian view: the market may be extrapolating a supply-constrained optical cycle as a permanent scarcity regime. Lead times are supportive for the next two quarters but can reverse quickly once module makers add capacity or hyperscalers shift architectures. A continued rally without upward revisions to 2027 earnings estimates would be a positioning signal, not fundamental confirmation.

Key Decisions for Investors

• Do not add directional MXL ahead of Oct. 28 after the recent momentum move; maintain only a tactical position if Q3 optical revenue, backlog conversion, and forward pricing commentary support another material 2027 estimate revision. Falsify the bullish case on weaker-than-guided optical mix, a pricing-concession signal, or reduced delivery visibility.
• Implement a 1-3 month relative-value pair: long CRDO / short MXL in equal dollar amounts, preferably initiated on further MXL strength into earnings. The thesis is multiple normalization rather than a broad AI downturn; target a 15-25% compression in the relative spread, with a stop if MXL discloses multiple new hyperscaler wins or materially raises its 2027 optical outlook.
• For lower-volatility AI-networking exposure, favor AVGO over MXL for a 6-18 month horizon. AVGO should retain upside from interconnect intensity while offering diversification against a single optical module program failing qualification.
• Set an alert for post-earnings estimate revisions: if MXL’s forward EPS estimates fail to rise by at least the magnitude implied by its optical outlook, reduce exposure rather than averaging down. The principal risk/reward asymmetry is valuation compression, not a collapse in end-market demand.